MMP15
Basic information
Region (hg38): 16:58025754-58046901
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 58 | 60 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 59 | 3 | 2 |
Variants in MMP15
This is a list of pathogenic ClinVar variants found in the MMP15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-58026375-G-A | not specified | Uncertain significance (Apr 28, 2022) | ||
16-58026382-C-G | not specified | Uncertain significance (May 08, 2023) | ||
16-58026391-C-G | not specified | Uncertain significance (Aug 13, 2021) | ||
16-58026397-G-C | not specified | Uncertain significance (Jun 11, 2021) | ||
16-58026490-A-C | not specified | Uncertain significance (Mar 21, 2022) | ||
16-58026506-T-A | not specified | Uncertain significance (Apr 15, 2024) | ||
16-58037481-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
16-58037482-G-A | not specified | Uncertain significance (Sep 19, 2022) | ||
16-58037512-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
16-58037526-A-C | not specified | Uncertain significance (May 24, 2023) | ||
16-58037607-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
16-58038277-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
16-58038282-C-A | not specified | Uncertain significance (Jan 04, 2024) | ||
16-58038306-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
16-58038313-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
16-58038331-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
16-58038337-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
16-58039889-C-T | not specified | Uncertain significance (May 08, 2023) | ||
16-58039928-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
16-58039930-A-G | not specified | Uncertain significance (May 14, 2024) | ||
16-58039939-C-T | not specified | Uncertain significance (May 09, 2023) | ||
16-58039968-C-T | Likely benign (May 31, 2018) | |||
16-58039996-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
16-58039997-G-A | not specified | Uncertain significance (May 05, 2023) | ||
16-58040011-A-G | not specified | Uncertain significance (Dec 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP15 | protein_coding | protein_coding | ENST00000219271 | 10 | 21336 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0734 | 0.927 | 125724 | 0 | 22 | 125746 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.33 | 374 | 453 | 0.825 | 0.0000328 | 4289 |
Missense in Polyphen | 104 | 150.54 | 0.69084 | 1281 | ||
Synonymous | -1.00 | 209 | 191 | 1.09 | 0.0000143 | 1384 |
Loss of Function | 3.73 | 8 | 30.0 | 0.266 | 0.00000172 | 286 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000174 | 0.000174 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000145 | 0.000139 |
European (Non-Finnish) | 0.0000834 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000171 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Endopeptidase that degrades various components of the extracellular matrix. May activate progelatinase A. {ECO:0000269|PubMed:9461298}.;
- Pathway
- Matrix Metalloproteinases;EMT transition in Colorectal Cancer;Collagen degradation;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.203
Intolerance Scores
- loftool
- 0.521
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 16.02
Haploinsufficiency Scores
- pHI
- 0.0810
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmp15
- Phenotype
- embryo phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- cellular protein modification process;proteolysis;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;response to estradiol;endodermal cell differentiation;positive regulation of catalytic activity
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;extracellular matrix
- Molecular function
- metalloendopeptidase activity;protein binding;enzyme activator activity;zinc ion binding;metalloaminopeptidase activity